Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
BioArctic (OTC : BRCTF) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
BioArctic AB is a research-based biopharmaceutical company. It is primarily focused on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of revenue from Asia.
Quote
| Last: | $35 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $35 |
| Close: | $35 |
| High: | $35 |
| Low: | $35 |
| Volume: | 250 |
| Last Trade Date Time: | 06/02/2026 12:48:19 pm |
Stock Data
| Market Cap: | $2,445,091,702 |
|---|---|
| Float: | 73,780,679 |
| Insiders Ownership: | N/A |
| Institutions: | |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Country: | SE |
| City: |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about BioArctic (OTC: BRCTF).
